BLOG

How to Evaluate a Stem Cell Clinic in Japan Before You Travel

7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Searching online for stem cell treatment abroad can be overwhelming. Clinics describe very different approaches, and it is not always clear which claims rest on solid information. If you are thinking about traveling to Japan for adipose-derived stem cell therapy, a calm, structured way of comparing providers can help you prepare for a conversation with a physician.

This article explains what to look at before you travel. It is general information, not medical advice. Whether this kind of treatment is suitable for you can only be judged by a doctor after an individual consultation.

The short answer: look at the system, the process, and the doctor

A useful evaluation rests on three pillars. First, how the clinic operates within Japan’s legal framework for regenerative medicine. Second, how clearly it can explain each step of the treatment, from tissue collection to cell culture and infusion. Third, how openly the physicians discuss uncertainty, risks, and costs. A clinic that is comfortable explaining the limits of current evidence is usually easier to evaluate than one that only talks about hoped-for outcomes.

Adipose-derived stem cell therapy, as offered at Grand Green Osaka Umekita Clinic, uses mesenchymal stem cells taken from a small amount of your own fat tissue. The cells are cultured and expanded at a specialized facility and then returned to the body by intravenous infusion. It is a self-pay treatment, and it is not covered by national health insurance.

Why careful evaluation matters in regenerative medicine

Stem cell research is active worldwide, and mesenchymal stem cells have been reported to secrete anti-inflammatory substances and growth factors that may support tissue repair. However, laboratory findings and early clinical reports do not automatically translate into dependable results for every individual. Medical societies and public agencies in several countries have repeatedly cautioned patients about stem cell interventions that are promoted without adequate evidence or oversight.

For that reason, it is reasonable to treat any promotional page, including a clinic’s own, as a starting point rather than a conclusion. Read primary sources where you can, such as summaries on PubMed or information from public health authorities, and bring your questions to a physician rather than relying on marketing language.

Understanding how Japan regulates cell therapy

In Japan, regenerative medicine provided as a medical practice is governed by the Act on the Safety of Regenerative Medicine. Under this law, a clinic that offers a cell-based treatment must prepare a provision plan for that specific treatment, have the plan reviewed by a certified committee, and submit it to the Minister of Health, Labour and Welfare. Cell culture and processing are expected to be carried out at facilities that meet defined standards.

This framework is a procedural safeguard, not a promise of any particular result. Still, it gives you something concrete to ask about. You can ask a clinic which provision plan covers the treatment you are considering, which processing facility handles the cells, and how adverse events are monitored and reported.

Questions to ask about the treatment process

A clear explanation of the workflow is one of the most practical signs of a well-organized clinic. For adipose-derived therapy, a typical sequence involves a consultation, a small fat collection under local anesthesia, a culture period while the cells are expanded, and then an outpatient infusion. Because the culture step takes time, international patients should confirm early how many visits are expected and how the schedule can fit with travel plans.

  • Who will examine me, and what screening is done before fat collection?
  • How long does cell culture take, and what happens if the cells do not grow as planned?
  • Is the treatment based on my own cells only, and how are they labeled and tracked?
  • What follow-up is available after I return home, and who should I contact if I have concerns?

Using your own cells, known as an autologous approach, is generally considered to lower the likelihood of rejection compared with donor cells. It does not remove all risk, and your physician should explain what applies to your situation.

Costs, risks, and who the treatment may not suit

Because this is a self-pay treatment, you should receive a clear explanation of fees, what each fee includes, and what is not included, before making any decision. Check the clinic’s official fee page and ask for written information. Be cautious about any provider that cannot or will not discuss costs and risks in advance.

Possible risks and side effects can include reactions related to fat collection, such as bruising, discomfort, or infection at the collection site, as well as reactions to the infusion. Your medical history, current medications, and existing conditions all influence whether treatment is appropriate. A responsible physician will also explain that regenerative therapy is not a substitute for standard medical care, and that you should continue to work with your regular doctors on any ongoing condition.

Preparing for a consultation at an Osaka clinic

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, which is easy to reach from Kansai International Airport and from Shin-Osaka station. The clinic provides an information page for international patients, so you can review the treatment overview, flow, and fees in your own language before contacting the staff.

To make the most of a first conversation, prepare a short summary of your medical history, a list of medications and supplements, and recent test results if you have them. Write down what you hope to understand, whether that is the treatment steps, expected timeline, costs, or possible risks. Then compare the answers you receive with the public information you have read, and take time to decide.

No single article can tell you whether adipose-derived stem cell therapy fits your circumstances. What you can do is ask structured questions, expect transparent answers, and let a physician’s individual assessment guide any decision.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact